Chemed Corp
(NYSE:CHE)
$
558.27
3.55 (0.64%)
Market Cap: 8.36 Bil
Enterprise Value: 8.22 Bil
PE Ratio: 28.21
PB Ratio: 6.77
GF Score: 95/100 
Chemed Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2020 / 05:30PM GMT
Release Date Price:
$477.33
(-0.18%)
David P. Williams
Chemed Corporation - Executive VP & CFO
This is Chemed. We're here.
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Yes. Hi, everyone. It's A.J. Rice, the health care service analyst at Credit Suisse. We're very happy to have next up speaking is Chemed Corporation.
We're joined today by Kevin McNamara, President and Chief Executive Officer; Dave Williams, Executive Vice President and Chief Financial Officer; and Nick Westfall, Chief Financial Officer of VITAS.
Nicholas Michael Westfall
VITAS Healthcare Corporation - CEO & President
CEO.
Albert J. William Rice;dit Suisse AG;David P.
CrÃ;Research Division - Research Analyst
© -
Oh, CEO, I'm sorry, VITAS. Sorry about that. Let me maybe pass it on to David to make a few comments, introductory sort of level set people that may be new to the Chemed story. And then we'll have some Q&A.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers